Published in:
Open Access
01-12-2021 | Respiratory Microbiota | Editorial
Emerging therapeutics
Author:
Gennaro Ciliberto
Published in:
Journal of Translational Medicine
|
Issue 1/2021
Login to get access
Excerpt
We are pleased to announce the launch of a new section in the Journal of Translational Medicine entitled “Emerging Therapeutics”. Scientific and technological advances are the necessary components in increasing our arsenal of weapons against complex diseases such as Cancer, Neurodegenerative and Cardiovascular diseases, Diabetes, Obesity as well as Infectious agents and, why not, also Aging. These days one of the most striking examples of emerging and highly successful technology is represented by the success of new genetic vaccines such as mRNA vaccines. With unprecedented short timelines, mRNA based vaccines have been able to demonstrate excellent safety and efficacy profiles in COVID-19 trials where they have received accelerated emergency approval, and are helping us overcome the SARS-CoV-2 pandemic crisis [
1,
2]. Hence, emerging therapeutics have received intense research efforts and high medical interest and it is for these reasons that a dedicated space has been provided by the Journal of Translational Medicine. …
